Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Establishment Labs Holdings Inc. or Insulet Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Establishment Labs Holdings Inc. and Insulet Corporation compare based on key financial metrics to determine which better meets your investment needs.

About Establishment Labs Holdings Inc. and Insulet Corporation

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Latest Health Care Equipment & Supplies and Establishment Labs Holdings Inc., Insulet Corporation Stock News

As of July 30, 2026, Establishment Labs Holdings Inc. had a $2.7 billion market capitalization, compared to the Health Care Equipment & Supplies median of $334.8 million. Establishment Labs Holdings Inc.’s stock is up 28% in 2026, up 1.1% in the previous five trading days and up 126.46% in the past year.

Currently, Establishment Labs Holdings Inc. does not have a price-earnings ratio. Establishment Labs Holdings Inc.’s trailing 12-month revenue is $229.6 million with a -19.1% net profit margin. Year-over-year quarterly sales growth most recently was 44.7%. Analysts expect adjusted earnings to reach $-1.015 per share for the current fiscal year. Establishment Labs Holdings Inc. does not currently pay a dividend.

As of July 30, 2026, Insulet Corporation had a $11.5 billion market cap, putting it in the 79th percentile of all stocks. Insulet Corporation’s stock is down 41.4% in 2026, up 2% in the previous five trading days and down 43.15% in the past year.

Currently, Insulet Corporation’s price-earnings ratio is 38.6. Insulet Corporation’s trailing 12-month revenue is $2.9 billion with a 10.4% net profit margin. Year-over-year quarterly sales growth most recently was 33.9%. Analysts expect adjusted earnings to reach $6.482 per share for the current fiscal year. Insulet Corporation does not currently pay a dividend.

How We Compare Establishment Labs Holdings Inc. and Insulet Corporation Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Establishment Labs Holdings Inc. and Insulet Corporation’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Establishment Labs Holdings Inc. and Insulet Corporation Stock Value Grades

Company	Ticker	Value
Establishment Labs Holdings Inc.	ESTA	F
Insulet Corporation	PODD	F

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Establishment Labs Holdings Inc. has a Value Score of 5, which is Ultra Expensive. Insulet Corporation has a Value Score of 17, which is Ultra Expensive.

The Value Stock Winner: No Clear Winner

Neither Establishment Labs Holdings Inc. or Insulet Corporation has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Establishment Labs Holdings Inc. or Insulet Corporation is the better investment when it comes to value.

Establishment Labs Holdings Inc. and Insulet Corporation’s Momentum Grades

Company	Ticker	Momentum
Establishment Labs Holdings Inc.	ESTA	A
Insulet Corporation	PODD	F

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Establishment Labs Holdings Inc. has a Momentum Score of 93, which is Very Strong. Insulet Corporation has a Momentum Score of 18, which is Very Weak.

The Momentum Grade Winner: Establishment Labs Holdings Inc.

As you can clearly see from the Momentum Grade breakdown above, Establishment Labs Holdings Inc. is considered to have stronger momentum compared to Insulet Corporation. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Establishment Labs Holdings Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Establishment Labs Holdings Inc. and Insulet Corporation’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Establishment Labs Holdings Inc.	ESTA	C
Insulet Corporation	PODD	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Establishment Labs Holdings Inc. has a Earnings Estimate Score of 47, which is Neutral. Insulet Corporation has a Earnings Estimate Score of 53, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Establishment Labs Holdings Inc. or Insulet Corporation has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Establishment Labs Holdings Inc. or Insulet Corporation is the better investment when it comes to estimate revisions.

Other Establishment Labs Holdings Inc. and Insulet Corporation Grades

In addition to Momentum, Value and Estimate Revisions, A+ Investor also provides grades for Growth and Quality.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Establishment Labs Holdings Inc. and Insulet Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Establishment Labs Holdings Inc. or Insulet Corporation Stock?

Overall, Establishment Labs Holdings Inc. stock has a Value Score of 5, Momentum Score of 93 and Estimate Revisions Score of 47.

Insulet Corporation stock has a Value Score of 17, Momentum Score of 18 and Estimate Revisions Score of 53.

Comparing Establishment Labs Holdings Inc. and Insulet Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.